| 265.30 Delayed Data As of May 23 |  0.00 / 0.00%Today’s Change | 214.46 Today|||52-Week Range 279.00 | +10.13% Year-to-Date |
| Previous close | 265.30 |
| Today’s open | 265.30 |
| Day’s range | 265.30 - 265.30 |
| Volume | 72 |
| Average volume (3 months) | 724 |
| Market cap | $41.5B |
| Earnings growth (last year) | +22.19% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +7.27% |
| P/E ratio | 20.6 |
| Price/Sales | 3.60 |
| Price/Book | 7.91 |
| No competitors data available. |
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $58.1B |
| Annual profit (last year) | $10.7B |
| Net profit margin | 18.47% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chief Executive Officer & Executive Director Severin Schwan |
Chief Financial & Information Technology Officer Alan Hippe |
Corporate headquarters Basel, Basel-stadt (basle Town) |
